Aurobindo Pharma Limited — JV/Acquisition, 10-07-2026: Acquisition

Aurobindo Pharma's step-down subsidiary, PT Aurogen Pharma Indonesia, has incorporated a new wholly-owned subsidiary, PT Auro Pharm Indonesia, in Indonesia. This strategic move, backed by an initial capital of IDR 20,000,000,000 for 100% control, is designed to establish manufacturing operations locally. This significant expansion into Indonesia strengthens Aurobindo's global manufacturing footprint and enhances its market presence in the pharmaceutical sector within the region, positioning the company for future growth.